Pricing, Packaging, and Demand Forecasting for a New Weight Loss Drug
1. How does Metabical compare to current weight-loss options?
* It was the only prescription drug to achieve the FDA * No side effects * Moderate weight loss for overweight people not the obese like other weightloss drugs * Dual layer controlled realise formulation. First layer appetite suppressant, 2nd layer is the fat blocker. Low dose levels of chemicals, so doesn’t cause heart or liver diseases.
2. What are the pros and cons of the forecasting methods presented by Printup? If you had to estimate demand for this product, how would you go about it? What would your demand (unit) forecast look like for the first five years? * Missing the broader potential target market, as they are only focusing solely on the 35 to 65 y.o educated females * More aggressively forecasted by using results from the Cambridge Sciences Pharmaceuticals (CSP) survey that specifically addresses the consumer interest in a prescription weight loss drug. * PROS: she developed the three models of approaches but the problem was all of them were based on assumptions. * Before making any recommendations, she must explore and analyse the assumptions to see if it’s true. * She must guarantee that the three models must be achievable before proceeding in with the new product. * Focus not only on the ideal target market, statistics says more males would be interested in weight loss products, therefore MUST expand target market.
3. What considerations should be taken into account when making decisions about the package count? What package size would you recommend? * Timing decisions and the pricing * They must have a breakeven/ balance for the pricing and the 12 week supply of the weight loss drug. (ie. You will be able to achieve optimal weight loss within 12 weeks of the drug, however paying for 12 weeks of the product is out of some people’s wage.) * The design of the packaging should reflect something of a childbirth control pill, as the
* It was the only prescription drug to achieve the FDA * No side effects * Moderate weight loss for overweight people not the obese like other weightloss drugs * Dual layer controlled realise formulation. First layer appetite suppressant, 2nd layer is the fat blocker. Low dose levels of chemicals, so doesn’t cause heart or liver diseases.
2. What are the pros and cons of the forecasting methods presented by Printup? If you had to estimate demand for this product, how would you go about it? What would your demand (unit) forecast look like for the first five years? * Missing the broader potential target market, as they are only focusing solely on the 35 to 65 y.o educated females * More aggressively forecasted by using results from the Cambridge Sciences Pharmaceuticals (CSP) survey that specifically addresses the consumer interest in a prescription weight loss drug. * PROS: she developed the three models of approaches but the problem was all of them were based on assumptions. * Before making any recommendations, she must explore and analyse the assumptions to see if it’s true. * She must guarantee that the three models must be achievable before proceeding in with the new product. * Focus not only on the ideal target market, statistics says more males would be interested in weight loss products, therefore MUST expand target market.
3. What considerations should be taken into account when making decisions about the package count? What package size would you recommend? * Timing decisions and the pricing * They must have a breakeven/ balance for the pricing and the 12 week supply of the weight loss drug. (ie. You will be able to achieve optimal weight loss within 12 weeks of the drug, however paying for 12 weeks of the product is out of some people’s wage.) * The design of the packaging should reflect something of a childbirth control pill, as the